These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 17038897)

  • 1. Treatment of hepatitis C virus infection (HCV) after renal transplantation: implications for HCV-positive dialysis patients awaiting a kidney transplant.
    Kamar N; Ribes D; Izopet J; Rostaing L
    Transplantation; 2006 Oct; 82(7):853-6. PubMed ID: 17038897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C infection and the patient with end-stage renal disease.
    Fabrizi F; Poordad FF; Martin P
    Hepatology; 2002 Jul; 36(1):3-10. PubMed ID: 12085342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hepatitis C virus infection in renal-transplant patients].
    Kamar N; Izopet J; Ribes D; Rostaing L
    Nephrologie; 2004; 25(1):9-15. PubMed ID: 15022868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hepatitis C infection among patients receiving hemodialysis].
    Kamar N; Izopet J; Rostaing L
    Nephrologie; 2003; 24(3):133-41. PubMed ID: 12814060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Is there a place for ribavirin in the treatment for renal transplant patients infected by hepatitis C virus?].
    Kamar N; Sandres-Saune K; Selves J; Durand D; Izopet J; Rostaing L
    Nephrologie; 2003; 24(2):89-94. PubMed ID: 12723514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical and immunologic impact of using interferon and ribavirin in the immunosuppressed host.
    Braun M; Vierling JM
    Liver Transpl; 2003 Nov; 9(11):S79-89. PubMed ID: 14586901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of interferon for chronic hepatitis C virus-related hepatitis in kidney transplant candidates on hemodialysis: results after transplantation.
    Casanovas-Taltavull T; Baliellas C; Benasco C; Serrano TT; Casanova A; Pérez JL; Guerrero L; González MT; Andres E; Gil-Vernet S; Casais LA
    Am J Gastroenterol; 2001 Apr; 96(4):1170-7. PubMed ID: 11316166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatitis C virus infection in renal diseases: state of knowledge, therapeutic problems and perspectives].
    Stachowski J
    Pol Merkur Lekarski; 2000 Apr; 8(46):303-6. PubMed ID: 10897663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribavirin dose modification based on renal function is necessary to reduce hemolysis in liver transplant patients with hepatitis C virus infection.
    Jain AB; Eghtesad B; Venkataramanan R; Fontes PA; Kashyap R; Dvorchik I; Shakil AO; Kingery L; Fung JJ
    Liver Transpl; 2002 Nov; 8(11):1007-13. PubMed ID: 12424713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained response with negative serum HCV-mRNA and disappearance of antibodies after interferon-alpha therapy in a kidney transplant recipient with chronic active viral hepatitis C.
    Luciani G; Bossola M; Muscaritoli M; Panocchia N; Ferrante A; Nanni G; Piccioni E; Tazza L; Grillo RL; Rossi Fanelli F; Castagneto M
    J Nephrol; 2003; 16(3):417-20. PubMed ID: 12832744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus infection and renal transplantation.
    Fabrizi F; Martin P; Ponticelli C
    Am J Kidney Dis; 2001 Nov; 38(5):919-34. PubMed ID: 11684543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune disease complicating antiviral therapy for hepatitis C virus infection.
    Wilson LE; Widman D; Dikman SH; Gorevic PD
    Semin Arthritis Rheum; 2002 Dec; 32(3):163-73. PubMed ID: 12528081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome of kidney transplantation in patients with hepatitis C virus infection.
    Huo TI; Yang WC; Wu JC; King KL; Lin CY; Loong CC; Lui WY; Chang FY; Lee SD
    Hepatogastroenterology; 2001; 48(37):169-73. PubMed ID: 11268958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of finding synergic in vitro drug-drug interactions between interferon-alpha and ribavirin for the treatment of hepatitis C virus.
    Buckwold VE
    J Antimicrob Chemother; 2004 Mar; 53(3):413-4. PubMed ID: 14963071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Viral hepatitis C in patients with renal disease].
    Contreras AM
    Rev Gastroenterol Mex; 2002 Oct; 67 Suppl 2():S88-92. PubMed ID: 12712863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of patients with recurrence or who do not respond to the first treatment against hepatitis C].
    Poo JL
    Rev Gastroenterol Mex; 2002 Oct; 67 Suppl 2():S45-8. PubMed ID: 12712853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-alpha and ribavirin treatment of hepatitis C in children with malignancy in remission.
    Christensson B; Wiebe T; Akesson A; Widell A
    Clin Infect Dis; 2000 Mar; 30(3):585-6. PubMed ID: 10722449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavirin.
    Gopal DV; Rabkin JM; Berk BS; Corless CL; Chou S; Olyaei A; Orloff SL; Rosen HR
    Liver Transpl; 2001 Mar; 7(3):181-90. PubMed ID: 11244158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of recurrence of hepatitis C infection following liver transplantation.
    Charlton M
    Minerva Chir; 2003 Oct; 58(5):717-24. PubMed ID: 14603150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Kidney transplantation in patients positive for hepatitis C virus].
    Campistol JM; Esforzado N; Morales JM; Barrera JM
    Nefrologia; 2002; 22 Suppl 5():62-6. PubMed ID: 12107920
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.